Chronic inflammation plays a critical role in the onset and progression of diabetes, highlighting the role of inflammation and the immune system in diabetes. In type 1 diabetes, autoimmune destruction of pancreatic beta cells results from dysregulated immune responses, while in type 2 diabetes, low-grade systemic inflammation contributes to insulin resistance. Pro-inflammatory cytokines such as TNF-α and IL-6 disrupt insulin signaling pathways, exacerbating metabolic dysfunction. Emerging therapies targeting inflammatory pathways, including immune-modulating drugs and anti-inflammatory diets, offer new possibilities for intervention. Research continues to explore how immune modulation can delay disease onset and improve long-term outcomes in diabetes management.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Belize Bible College, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States